Spike Protein News and Research

RSS
Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

mRNA vaccines induce faster antibody response against infectious diseases

mRNA vaccines induce faster antibody response against infectious diseases

Routine periodic fasting associated with lower hospitalization risk in patients with COVID-19

Routine periodic fasting associated with lower hospitalization risk in patients with COVID-19

Study finds a column containing a Galanthus nivalis agglutinin affinity resin can bind all the major COVID-19 variants

Study finds a column containing a Galanthus nivalis agglutinin affinity resin can bind all the major COVID-19 variants

How and when do de novo SARS-CoV-2 spike mutations emerge?

How and when do de novo SARS-CoV-2 spike mutations emerge?

What is the immunopathogenesis of pediatric COVID-19?

What is the immunopathogenesis of pediatric COVID-19?

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Moderna COVID vaccine is more effective in older and sicker veterans over time

Moderna COVID vaccine is more effective in older and sicker veterans over time

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Predicting viral antibody escape using pre-pandemic data

Predicting viral antibody escape using pre-pandemic data

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

Does vaccine- or infection-induced immunity protect less well against infection by specific SARS-CoV-2 variants?

Does vaccine- or infection-induced immunity protect less well against infection by specific SARS-CoV-2 variants?

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

New COVID vaccine patch could better fight variants than a traditional needle, finds study

New COVID vaccine patch could better fight variants than a traditional needle, finds study

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.